Part of the dynamic ASEAN region, Singapore is fast-realising its ambitions of becoming a regional IP hub. And as an IP gateway to Asia, we have selected Singapore as the ideal location in which to bring together the IP counsel of established pharmaceutical and biotechnology companies, as well as the legal counsel of fledgling life-sciences companies – along with global IP experts, to present, discuss and debate today’s critical patent considerations across Asia and further afield, over the course of just one invaluable day.
Brought to you by the publisher of Life Sciences IP Review, LSPN Asia follows on from the hugely successful LSPN Europe and North America conferences, attended by upwards of one hundred in-house pharma and biotech counsel. Our Patent Network events are designed to be intimate and as such, places are strictly limited. If you need to learn more about Asia’s varying patent jurisdictions and meet face-to-face with your in-house patent counsel and private practice attorney peers, I urge you to register without delay.
In the same way as at the conferences in London and Boston, the Singapore conference will take a broad global view of the patent protection landscape and then delve deeper into the regional topics of specific current interest. Extended round table discussion groups enable a couple of hours to be spent in small groups, sharing views on a range of topics of your choosing. For fledgling bio-pharma manufacturers, the conference will feature an open clinic to enable in-house counsel to quiz specialist private patent attorneys from around the globe on their own specific pressing patent issues.
Senior Legal Counsel, Zymergen
VP, Global Intellectual Property, AstraZeneca
Partner , Adams & Adams
SVP Legal and Secretary, Jounce Therapeutics
Senior Legal Counsel, Novartis
SVP, Legal Affairs, Relay Therapeutics
Associate VP & Director of Technology Licensing & Commercialization, Georgia State University
Patent Counsel, Seven Bridges Genomics
Director, Intellectual Property & Contracts, Medicago Inc
Vice President, Intellectual Property, Alnylam Pharmaceuticals Inc
General Counsel , Ranarx
Partner, Powell Gilbert
PhD Candidate, Yale University, Pieris Pharmaceuticals
Shareholder, Wolf Greenfield
Partner, King & Wood Mallesons
Managing Principal, Marks & Clerk
Senior Director, Patent Counsel, Alexion Pharmaceuticals
Associate Counsel, Karyopharm Therapeutics Inc
Intellectual Property Paralegal, Conagen Inc.
VP, Head of Intellectual Property, Vedanta Bio Sciences
Intellectual Property Partner, White & Case
Partner, Lathrop & Gage
Partner, Smart & Biggar
Senior IP Operations Manager, KWS SAAT SE
Vice President - Intellectual Property, Dicerna Pharmaceuticals
Director, Patent Attorney, Regeneron Pharmaceuticals
Senior Director of Dispute Resolution, Regeneron
Content Manager, RoyaltyStat
Senior Vice President & General Counsel, Catabasis Pharmaceuticals Inc
Global Head of IP, Allen & Overy
Business Development, Darts-ip
VP Head Group Intellectual Property, UCB
Legal Counsel, IP and Contracts, VBI Vaccines Inc.
Senior Director, Business Development, RWS
Director, Sterne Kessler Goldstein & Fox
Patent Practitioner, ImmunoGen
Business Development, RoyaltyStat
Senior Director, Business Development, RWS
Senior Corporate Counsel, Sanofi
Second Vice President, American Intellectual Property Law Association
Patent Attorney II, NIBR
Principal, Fish & Richardson
Patent Agent , ROBIC
Head of Intellectual Property, Seres Therapeutics
Partner, Allen & Overy
Partner, Powell Gilbert
Patent Counsel, Wan Hui Da
Senior Director IP, Research & Development, ImmunoGen
Patent Agent, Wolf Greenfield
Partner, Christensen, Fonder, Dardi & Herbert
Partner, Zhongzi Law Office
Associate, Nutter McClennen & Fish
Attorney - Partner, Fish & Richardson
Partner, Fitzpatrick Cella Harper & Scinto
Principal Counsel, Head of Biologic Patents US, Sanofi
VP Intellectual Property, Paratek Pharmaceuticals
Attorney at Law, Sterne Kessler Goldstein & Fox
SVP, General Counsel, Karyopharm Therapeutics
Senior Counsel, AbbVie
Partner, Gowling WLG
Senior Partner, Wan Hui Da
Senior Director & Senior Patent Counsel, Alnylam Pharmaceuticals
Head of Licensing and IP Strategy, MilliporeSigma
Partner, Smart & Biggar
Intellectual Property Partner, White & Case
Partner and Boston Office Co-Managing Partner, Saul Ewing
Senior Patent Counsel, Global IP, Sanofi
Vice President & Chief Counsel IP, Thermo Fisher Scientific Inc
Senior Partner, Wan Hui Da
Director of Intellectual Property, Jounce Therapeutics
Senior Associate, Allen & Overy
Partner, Nutter McClennen & Fish
Principal, Fish & Richardson
Director, Intellectual Property, Blueprint Medicines
Chief IP Counsel, Bioverativ
Patent Agent, Aird & McBurney
Partner, Nelson Mullins Riley & Scarborough
Patent Agent, Alnylam Pharmaceuticals
VP, Patent Head Oncology & IP Site Head, Novartis
Counsel, Choate Hall & Stewart
Senior Corporate Patent Counsel, MilliporeSigma
Vice President, Head of Intellectual Property, Ranarx
Vice President Licensing, IP & Legal Affairs, Pieris Pharmaceuticals
Senior Manager, Takeda Oncology
Associate Director of IP, Alnylam Pharmaceuticals
Partner, White & Case
Director of Legal Affairs, Conagen Inc.
Marina Bay Sands is a premier entertainment destination with its vibrant diversity of attractions and facilities. The vision was to build an integrated development that is timeless, a landmark that possesses a distinct identity which distinguishes Singapore from other cities.
Located along the Marina Bay waterfront, Marina Bay Sands features three cascading hotel towers topped by an extraordinary sky park, 'floating' crystal pavilions, a lotus-inspired Museum, retail stores featuring cutting-edge labels and international luxury brands, trendy Celebrity Chef restaurants, endless entertainment at the theatres, the hottest night clubs and a Las Vegas-style casino. Business visitors will also enjoy the extensive Meetings, Incentives, Conventions and Exhibitions (MICE) facilities featuring state-of-the-art technology, highly flexible exhibition halls, and a convention centre that can host over 45,000 delegates.
We have secured a limited number of discounted rooms at the venue. If you are interested in booking a room at the Marina Bay Sands please contact us as soon as possible to secure the discounted room rate.
Commerical Director
+44 (0) 203 301 8211
+44 (0) 7957672202
